3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow simurosertib: new trials by email Literature Review of simurosertib trials Research Report on simurosertib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors TAK-931 PIC, TAK-931 Tablet, Esomeprazole - Neoplasms, Advanced Solid | Phase 1 | Completed | Millennium Pharmaceuticals, Inc. | 20 | 2019-03-28 | 2020-12-29 |
| A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors TAK-931 - Metastatic Pancreatic Cancer, Colorectal Cancer | Phase 2 | Completed | Millennium Pharmaceuticals, Inc. | 101 | 2017-10-25 | 2021-09-20 |
| A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors TAK-931 - Nonhematologic Neoplasms, Advanced | Phase 1 | Completed | Millennium Pharmaceuticals, Inc. | 80 | 2016-03-24 | 2021-02-21 |
Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
Millennium Pharmaceuticals, Inc. (3)
Japan (2) · Netherlands (1) · United States (1)
PMID 36338546, PMID 36409435, PMID 36970056
2017 (1)